is associated with the memory loss. In this work, a new guanylhydrazone was designed and synthesized as an AChE inhibitor. This new compound was compared to tacrine and other guanylhydrazones. All of them were studied by molecular docking and tested in vitro as AChE inhibitors by Ellman's test and Fig-NMR method. A high inhibition of AChE by the new compound was observed, showing that this compound has
由于这是痴呆症的最常见类型,因此开发用于治疗阿尔茨海默氏病(AD)的药物非常重要。抑制
乙酰胆碱酯酶(AChE)对于增加在患者中观察到的低
水平的
乙酰胆碱(ACh)神经递质很重要,这与记忆力丧失有关。在这项工作中,设计并合成了一种新的
胍hydr作为AChE
抑制剂。将该新化合物与
他克林和其他
胍基compared进行了比较。所有这些均通过分子对接研究,并通过Ellman试验和Fig-NMR法在体外作为AChE
抑制剂进行了测试。观察到新化合物对AChE的高度抑制作用,表明该化合物具有治疗AD的巨大潜力。